Serum levels of 25-hydroxyvitamin D predicts infarct volume and mortality in ischemic stroke patients

Journal of Neuroimmunology

Volumn 313, Issue , 2017, Pages 41-45

  Nie, Zhong ^a   Ji, Xiao Chun ^a   Wang, Jian ^a   Zhang, Hong Xing ^b  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Luoyang Bone Setting Hospital   (China)

Author keywords

25 Hydroxyvitamin D; Cardiovascular disease; Ischemic stroke; Mortality

Indexed keywords

25 HYDROXYVITAMIN D; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; COMPLICATION; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; IMAGE PROCESSING; LONGITUDINAL STUDY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BRAIN INFARCTION; BRAIN ISCHEMIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; VITAMIN D;

EID: 85031820894     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2017.10.002     Document Type: Article

References (37)

1. Amrein, K., Zajic, P., Schnedl, C. et al., Vitamin D status and its association with season, hospital and sepsis mortality in critical illness. Crit. Care, 18(2), 2014, 1.
2. Bischoff-Ferrari, H., Vitamin D: what is an adequate vitamin D level and how much supplementation is necessary. Best Pract. Res. Clin. Rheumatol. 23:6 (2009), 789–795.
3. Brøndum-Jacobsen, P., Nordestgaard, B.G., Schnohr, P. et al., 25-Hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann. Neurol. 73:1 (2013), 38–47.
4. Brott, T., Adams, H.P. Jr., Olinger, C.P., Marler, J.R., Barsanl, W.G., Biller, J. et al., Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20 (1989), 864–870.
5. Chowdhury, R., Kunutsor, S., Vitezova, A. et al., Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ, 348, 2014, g1903.
6. Daubail, B., Jacquin, A., Guilland, J.C. et al., Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients. Eur. J. Neurol. 20:1 (2013), 57–61.
7. Daubail, B., Jacquin, A., Guilland, J.C., Khoumri, C., Aboa-Eboulé, C., Giroud, M. et al., Association between serum concentration of vitamin D and 1-year mortality in stroke patients. Cerebrovasc. Dis. 37:5 (2014), 364–367.
8. Durazo-Arvizu, R.A., Dawson-Hughes, B., Kramer, H. et al., The reverse J-shaped association between serum total 25-hydroxyvitamin D concentration and all-cause mortality: the impact of assay standardization. Am. J. Epidemiol. 185:8 (2017), 720–726.
9. Durup, D., Jørgensen, H.L., Christensen, J. et al., A reverse J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality: the CopD Study. The Journal of Clinical Endocrinology & Metabolism 100:6 (2015), 2339–2346.
10. Feldman, D., Krishnan, A.V., Swami, S. et al., The role of vitamin D in reducing cancer risk and progression. Nat. Rev. Cancer 14:5 (2014), 342–357.
11. Forman, J.P., Giovannucci, E., Holmes, M.D. et al., Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49:5 (2007), 1063–1069.
12. Gaksch, M., Jorde, R., Grimnes, G. et al., Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One, 12(2), 2017, e0170791.
13. Généreux, P., Head, S.J., Van Mieghem, N.M., Kodali, S., Kirtane, A.J., Xu, K. et al., Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J. Am. Coll. Cardiol. 59 (2012), 2317–2326.
14. Ginde, A.A., Scragg, R., Schwartz, R.S. et al., Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older US adults. J. Am. Geriatr. Soc. 57:9 (2009), 1595–1603.
15. Gong, Z.L., Luo, C.M., Wang, L. et al., Serum 25-hydroxyvitamin D levels in Chinese children with autism spectrum disorders. Neuroreport 25:1 (2014), 23–27.
16. Hewison, M., Antibacterial effects of vitamin D. Nat. Rev. Endocrinol. 7 (2011), 337–345.
17. Huang, H., Zheng, T., Wang, S. et al., Serum 25-hydroxyvitamin D predicts early recurrent stroke in ischemic stroke patients. Nutr. Metab. Cardiovasc. Dis. 26:10 (2016), 908–914.
18. Kunadian, V., Ford, G.A., Bawamia, B., Qiu, W., Manson, J.E., Vitamin D deficiency and coronary artery disease: a review of the evidence. Am. Heart J. 167:3 (2014), 283–291.
19. Melamed, M.L., Michos, E.D., Post, W. et al., 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 168:15 (2008), 1629–1637.
20. Michaëlsson, K., Baron, J.A., Snellman, G. et al., Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am. J. Clin. Nutr. 92:4 (2010), 841–848.
21. Mooy, J.M., Grootenhuis, P.A., de Vries, H. et al., Prevalence and determinants of glucose intolerance in a Dutch Caucasian population: the Hoorn Study. Diabetes Care 18:9 (1995), 1270–1273.
22. Palomer, X., González-Clemente, J.M., Blanco-Vaca, F. et al., Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes. Metab. 10:3 (2008), 185–197.
23. Park, K.Y., Chung, P.W., Kim, Y.B., Moon, H.S., Suh, B.C., Won, Y.S. et al., Serum vitamin D status as a predictor of prognosis in patients with acute ischemic stroke. Cerebrovasc. Dis. 40:1–2 (2015), 73–80.
24. Pencina, M.J., D'Agostino, R.B. Sr., D'Agostino, R.B. Jr., Vasan, R.S., Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med. 27 (2008), 157–172.
25. Pilz, S., Dobnig, H., Fischer, J.E., Wellnitz, B., Seelhorst, U., Boehm, B.O., März, W., Low Vitamin, D., Levels predict stroke in patients referred to coronary angiography. Stroke 39 (2008), 2611–2613.
26. Pilz, S., Dobnig, H., Nijpels, G. et al., Vitamin D and mortality in older men and women. Clin. Endocrinol. 71:5 (2009), 666–672.
27. Pilz, S., Iodice, S., Zittermann, A. et al., Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am. J. Kidney Dis. 58:3 (2011), 374–382.
28. Pittas, A.G., Lau, J., Hu, F.B. et al., The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 92:6 (2007), 2017–2029.
29. Schneider, A.L.C., Lutsey, P.L., Selvin, E. et al., Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study. Eur. J. Neurol. 22:8 (2015), 1220–1227.
30. Semba, R.D., Houston, D.K., Bandinelli, S. et al., Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur. J. Clin. Nutr. 64:2 (2010), 203–209.
31. Sims, J.R., Gharai, L.R., Schaefer, P.W., Vangel, M., Rosenthal, E.S., ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72 (2009), 2104–2110.
32. Snijder, M.B., Lips, P., Seidell, J.C. et al., Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J. Intern. Med. 261:6 (2007), 558–565.
33. Tentori, F., Hunt, W.C., Stidley, C.A. et al., Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int. 70:10 (2006), 1858–1865.
34. Tu, W.J., Zhao, S.J., Xu, D.J. et al., Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke. Clin. Sci. 126:5 (2014), 339–346.
35. Welles, C.C., Whooley, M.A., Karumanchi, S.A. et al., Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am. J. Epidemiol. 179:11 (2014), 1279–1287.
36. White, J.H., Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect. Immun. 76:9 (2008), 3837–3843.
37. Yusuf, S., Sleight, P., Pogue, J. et al., Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N. Engl. J. Med. 342:3 (2000), 145–153.